Form 4 for QDEL QuidelOrtho Corp
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0000899243-22-020482 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-27 | QDEL | Dilsaver Evelyn S | Dir | A - Grant | — | +274 | 274 | New | — |
| D | 2022-06-01 | 2022-05-27 | QDEL | Dilsaver Evelyn S | Dir | A - Grant | $0.00 | +275 | 275 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | A | A | 274 | — | 274 | D | — | — | (F1) Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash. |
| 2 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 275 | $0.00 | 275 | D | — · — to — | 275 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F4) 204 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 71 shares will vest on March 31, 2023. |